These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17396728)

  • 61. The erythromycin-resistance in S. pyogenes does not limit the human polymorphonuclear cell antimicrobial activity.
    Cuffini AM; Tullio V; Banche G; Allizond V; Mandras N; Roana J; Scalas D; Carlone NA
    Int J Immunopathol Pharmacol; 2009; 22(1):239-42. PubMed ID: 19309572
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of penicillin and erythromycin on adherence of invasive and noninvasive isolates of Streptococcus pyogenes to laminin.
    Šmitran A; Vuković D; Gajić I; Marinković J; Ranin L
    Mem Inst Oswaldo Cruz; 2015 Aug; 110(5):684-6. PubMed ID: 26270594
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel 12-membered ring macrolides with activity against erythromycin-resistant organisms.
    Nemoto PA; Zhang X; Djuric S; Ma Z
    J Antibiot (Tokyo); 2003 Apr; 56(4):392-8. PubMed ID: 12817813
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy.
    Dicuonzo G; Fiscarelli E; Gherardi G; Lorino G; Battistoni F; Landi S; De Cesaris M; Petitti T; Beall B
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3987-90. PubMed ID: 12435707
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Detecting erythromycin resistance in Streptococcus pyogenes: reliability of the disk diffusion method and the breakpoint susceptibility testing method. Finnish Study Group for Antimicrobial Resistance (FIRE).
    Nissinen A; Seppälä H; Huovinen P
    Scand J Infect Dis; 1995; 27(1):52-6. PubMed ID: 7784814
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trends in Streptococcus pyogenes resistance to erythromycin in Slovakia: is there a correlation with consumption?
    Krcmery V; Foltan V; Langsadl L; Liskov A; Babela R
    Scand J Infect Dis; 2002; 34(5):400. PubMed ID: 12069033
    [No Abstract]   [Full Text] [Related]  

  • 67. Viridans group streptococci: a reservoir of resistant bacteria in oral cavities.
    Bryskier A
    Clin Microbiol Infect; 2002 Feb; 8(2):65-9. PubMed ID: 11952717
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [In vitro bactericidal action of a complex of natural cytokins on Streptococcus pyogenes].
    Koval'chuk LV; Gankovskaia LV; Avedova TA; Briko NI; Eshchina AS; Dmitrieva NF
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):67-71. PubMed ID: 16830594
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Susceptibility of skin and throat strains of group A streptococci to rosamicin and erythromycin.
    Saroglou G; Bisno AL
    Antimicrob Agents Chemother; 1978 Apr; 13(4):701-2. PubMed ID: 27141
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lactobacillus rhamnosus GG inhibits invasion of cultured human respiratory cells by prtF1-positive macrolide-resistant group A streptococci.
    Princivalli MS; Paoletti C; Magi G; Palmieri C; Ferrante L; Facinelli B
    Lett Appl Microbiol; 2009 Mar; 48(3):368-72. PubMed ID: 19187508
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A rapid screening method for detecting active compounds against erythromycin-resistant bacterial strains of Finnish origin.
    Kreander K; Vuorela P; Tammela P
    Folia Microbiol (Praha); 2005; 50(6):487-93. PubMed ID: 16681145
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [New Actions of macrolides. General topics. Summary of discussion. (2)].
    Tateda K
    Jpn J Antibiot; 2009 Mar; 62 Suppl A():67. PubMed ID: 22454853
    [No Abstract]   [Full Text] [Related]  

  • 73. Greenville County special cancer project.
    Grimball GM
    J S C Med Assoc; 1965 Sep; 61(9):264-6. PubMed ID: 5212727
    [No Abstract]   [Full Text] [Related]  

  • 74. University of South Carolina School of Medicine Greenville.
    Buchanan AO; Elkhider IA; Sharkey AM
    Acad Med; 2020 Sep; 95(9S A Snapshot of Medical Student Education in the United States and Canada: Reports From 145 Schools):S465-S468. PubMed ID: 33626745
    [No Abstract]   [Full Text] [Related]  

  • 75. Effectiveness Assessment When Pharmacokinetics Makes A Difference, Macrolides And Azalide Example.
    Francetic I
    Clin Ther; 2016 Oct; 38(10S):e8-e9. PubMed ID: 27673677
    [No Abstract]   [Full Text] [Related]  

  • 76. Group A Streptococcus: another resistant pathogen.
    LaCroix R; Rye AK
    South Med J; 2007 Mar; 100(3):260-1. PubMed ID: 17396728
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
    Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
    J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia.
    Pavlovic L; Grego E; Sipetic-Grujicic S
    Jpn J Infect Dis; 2010 Jul; 63(4):275-6. PubMed ID: 20657068
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Emergence of macrolide resistant Streptococcus pyogenes strains in pediatric patients in France].
    Mariani-Kurkdjian P; Doit C; Deforche D; Brahimi N; Francois M; Van den Abbeele T; Bingen E
    Pathol Biol (Paris); 2004 Oct; 52(8):489-92. PubMed ID: 15465270
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
    Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
    Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.